Filing Details
- Accession Number:
- 0000899243-21-017261
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-28 20:30:09
- Reporting Period:
- 2021-04-26
- Accepted Time:
- 2021-04-28 20:30:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1622229 | Cogent Biosciences Inc. | COGT | Pharmaceutical Preparations (2834) | 465308248 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709773 | L. John Green | C/O Cogent Biosciences, Inc. 200 Cambridge Park Drive, Suite 2500 Cambridge MA 02140 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-26 | 17,813 | $8.86 | 3,841 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person.
- The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
Billionaire Hedge Funds
